LifePoint Health (LPNT) Getting Positive Media Coverage, Accern Reports

Media headlines about LifePoint Health (NASDAQ:LPNT) have trended positive on Friday, Accern Sentiment reports. Accern rates the sentiment of news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. LifePoint Health earned a media sentiment score of 0.45 on Accern’s scale. Accern also gave news headlines about the company an impact score of 45.3234210038052 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Shares of LifePoint Health (LPNT) opened at $48.85 on Friday. The stock has a market cap of $1,930.00, a PE ratio of 11.58, a P/E/G ratio of 1.08 and a beta of 0.52. The company has a quick ratio of 1.65, a current ratio of 1.85 and a debt-to-equity ratio of 1.24. LifePoint Health has a one year low of $42.50 and a one year high of $70.95.

LifePoint Health declared that its board has authorized a stock buyback plan on Friday, October 27th that authorizes the company to repurchase $200.00 million in outstanding shares. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares repurchase plans are generally an indication that the company’s leadership believes its shares are undervalued.

LPNT has been the subject of a number of recent research reports. Raymond James Financial restated a “market perform” rating on shares of LifePoint Health in a research note on Monday, October 30th. Robert W. Baird set a $55.00 price objective on shares of LifePoint Health and gave the stock a “buy” rating in a research note on Monday, October 30th. SunTrust Banks set a $54.00 price objective on shares of LifePoint Health and gave the stock a “hold” rating in a research note on Tuesday, October 31st. William Blair restated an “outperform” rating on shares of LifePoint Health in a research note on Tuesday, November 21st. Finally, Citigroup reduced their price objective on shares of LifePoint Health from $70.00 to $60.00 and set a “buy” rating for the company in a research note on Monday, October 30th. One research analyst has rated the stock with a sell rating, fifteen have issued a hold rating and five have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $58.67.

In other LifePoint Health news, insider David M. Dill sold 45,000 shares of the stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $48.52, for a total value of $2,183,400.00. Following the transaction, the insider now directly owns 252,673 shares of the company’s stock, valued at approximately $12,259,693.96. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Marguerite Kondracke sold 3,907 shares of the stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $44.73, for a total transaction of $174,760.11. The disclosure for this sale can be found here. Over the last three months, insiders sold 52,323 shares of company stock worth $2,507,781. Insiders own 8.76% of the company’s stock.

WARNING: “LifePoint Health (LPNT) Getting Positive Media Coverage, Accern Reports” was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international copyright and trademark law. The legal version of this report can be viewed at https://ledgergazette.com/2018/02/16/lifepoint-health-lpnt-getting-positive-media-coverage-accern-reports.html.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Insider Buying and Selling by Quarter for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply